Key facts
- It has raised $2.2M; the latest was Angel (individual) ($2.2M) in Mar 2025.
- Notable investors include Antonio Parente, BioIncubaTech, Business Factory Food, José Río, Mauricio Peralta — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Smart Vitamins
- ·The full record, as it builds
Funding rounds
No funding rounds for Smart Vitamins are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Smart Vitamins
Developer of drug technology designed to prevent autoimmune and infectious diseases. The company offers bioactive nanocapsules that enhance the delivery of active compounds to the immune system and a clinical-stage candidate with prophylactic effects against respiratory viruses, enabling pharmaceutical and healthcare providers to improve disease prevention and immune response effectiveness.
- Sector
- Healthcare
- HQ
- Santiago de Compostela, Spain
- Founded
- 2020
- Employees
- 5
- Website
- smartvitamins.org/
- Ownership
- Privately Held (backing)
Smart Vitamins doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Smart Vitamins shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Smart Vitamins in its N-PORT filings yet. We sweep new filings monthly.